Archives of Head and Neck Surgery
https://www.archivesheadnecksurgery.com/article/doi/10.4322/ahns.2018.0020
Archives of Head and Neck Surgery
Original Article Head and neck cutaneous tumors

Clinical and epidemiological profile of patients with cutaneous neoplasia treated in an oncological hospital in Maranhão, Brazil

Adriana Aila Rocha Araújo, Cláudia Tamires Sousa Leite, Cássia Talita Sousa Leite, Fabiane Barbosa de Castro Lima Santos, Stênio Roberto de Castro Lima Santos

Downloads: 1
Views: 1081

Abstract

Introduction: Cutaneous neoplasms can be classified as melanoma and non-melanoma, and the non-melanoma subtype is the most prevalent among the Brazilian population. The most frequent histological types are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Objective: To evaluate a skin cancer series at the Aldenora Bello Cancer Hospital. Materials and Methods: A retrospective and descriptive study was carried out using a chart analysis that used demographic and clinical variables of 462 patients with cutaneous neoplasia of the non-melanoma type at the Maranhense Institute of Oncology Aldenora Bello, from January to December 2016. Results: The analysis showed that 71% of the lesions were basal cell carcinomas, with major involvement of the nasal region. The most used treatment was surgical resection and reconstruction by means of graft or flap. Conclusion The patients follow-up after surgical resection is important, since approximately 30% of them reported having had at least one previous lesion and of these, around 9% were cases of recurrence.

Keywords

cutaneous neoplasia; basal cell; squamous cell.

References

1. Instituto Nacional do Câncer. Estimativa da incidência mortalidade e por câncer de pele não melanoma [Internet]. 2017 [cited 2017 October 29]. Available from: http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/pelenaomelanoma

2. Benedet L, Bastos MF, Teixeira JF, Miranda LF, Bolan R. Avaliação clínica e histopatológica dos pacientes portadores de carcinoma basocelular diagnosticados no instituto de diagnóstico anátomo-patológico em Florianópolis-SC de janeiro a fevereiro de 2004. ACM Arq Catarin Med. 2007;36(1):37-44.

3. Noury K. Skin cancer. Nova Iorque: McGraw Hill; 2007.

4. Silva, TDCN, Silva GLS Jr, ALBUQUERQUE RB, OLIVEIRA ERRS, BATISTA KRF. Estudo retrospectivo de aspectos epidemiológicos, clínicos e histológicos na neoplasia de pele não melanoma. Rev Bras Cir Cabeça Pescoço, 2016;45(1):1-6.

5. Instituto Nacional do Câncer. Tipos de câncer: pele melanoma [Internet]. 2017 [cited 2017 October 29]. Available from: http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/ pele_melanoma

6. Sociedade Brasileira de Dermatologia. Câncer de pele [Internet]. 2017 [cited 2017 October 29]. Available from: http://www.sbd.org.br/dermatologia/pele/doencas-e-problemas/cancer-da-pele/64/

7. English DR, Armstrong BK, Kricker A, Winter MG, Heenan PJ, Randell PL. Demographic characteristics, pigmentary and cutaneous risk factors for squamous cell carcinoma of the skin: a case-control study. Int J Cancer. 1998;76(5):628- 34. http://dx.doi.org/10.1002/(SICI)1097-0215(19980529)76:5<628::AIDIJC3>3.0.CO;2-S. PMid:9610717.

8. Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS, Williams HC. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol. 2014;15(1):96-105. http://dx.doi.org/10.1016/S1470-2045(13)70530-8. PMid:24332516.

9. Rhodes LE, de Rie M, Enström Y, Groves R, Morken T, Goulden V, Wong GAE, Grob J-J, Varma S, Wolf P. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol. 2004;140(1):17-23. http://dx.doi.org/10.1001/archderm.140.1.17. PMid:14732655.

10. Van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, Steijlen PM, Neumann HA, Nelemans PJ, Kelleners-Smeets NW. Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014;50(17):3011-20. http://dx.doi.org/10.1016/j.ejca.2014.08.018. PMid:25262378.

11. Gulleth Y, Goldberg N, Silverman RP, Gastman BR. What is the best surgical margin for a Basal cell carcinoma: a meta-analysis of the literature. Plast Reconstr Surg. 2010;126(4):1222-31. http://dx.doi.org/10.1097/PRS.0b013e3181ea450d. PMid:20885244.

12. Lansbury L, Bath-Hextall F, Perkins W, Stanton W, Leonardi-Bee J. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ 2013; 347:f6153. http://dx.doi.org/10.1136/bmj.f6153.

13. Veness MJ, Porceddu S, Palme CE, Morgan GJ. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29(7):621-31. PMid:17230560.

14. Karia PS, Jambusaria-Pahlajani A, Harrington DP, Murphy GF, Qureshi AA, Schmults CD. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women’s Hospital tumor staging for cutaneous squamous cell carcinoma. J Clin Oncol. 2014;32(4):327-34. http://dx.doi.org/10.1200/JCO.2012.48.5326. PMid:24366933.

15. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976-90. http://dx.doi.org/10.1016/0190-9622(92)70144-5. PMid:1607418.

16. Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol. 2012;106(7):811-5. http://dx.doi.org/10.1002/jso.23155. PMid:22592943.

17. Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg. 2006;32(11):1309-21. PMid:17083582.

18. Part II. Head and neck. In: Amid MB, editors. AJCC cancer staging manual. 8th ed. New York: Springer; 2017. p. 53.

19. Veness MJ, Porceddu S, Palme CE, Morgan GJ. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29(7):621-31. http://dx.doi.org/10.1002/hed.20576. PMid:17230560.

20. Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer. 2006;106(11):2389-96. http://dx.doi.org/10.1002/cncr.21898. PMid:16649220.

21. Tavin E, Persky M. Metastatic cutaneous squamous cell carcinoma of the head and neck region. Laryngoscope. 1996;106(2 Pt 1):156-8. http://dx.doi.org/10.1097/00005537-199602000-00009. PMid:8583845.

22. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976-90. http://dx.doi.org/10.1016/0190-9622(92)70144-5. PMid:1607418.

23. Krediet JT, Beyer M, Lenz K, Ulrich C, Lange-Asschenfeldt B, Stockfleth E, Terhorst D. Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Br J Dermatol. 2015;172(4):1029-36. http://dx.doi.org/10.1111/bjd.13508. PMid:25362868.

5c8b9c210e8825311cdb04aa archives Articles
Links & Downloads

Arch. Head Neck Surg.

Share this page
Page Sections